These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 26953392)

  • 1. [Do corticoids affect the anti-CCP titer?].
    MMW Fortschr Med; 2015 Nov; 157(19):20. PubMed ID: 26953392
    [No Abstract]   [Full Text] [Related]  

  • 2. Insights to clinical use of serial determination in titers of cyclic citrullinated peptide autoantibodies.
    Kogure T; Tatsumi T; Fujinaga H; Niizawa A; Terasawa K
    Mediators Inflamm; 2007; 2007():12367. PubMed ID: 17497027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rheumatoid factor and anti-CCP autoantibodies in rheumatoid arthritis: a review.
    Lee AN; Beck CE; Hall M
    Clin Lab Sci; 2008; 21(1):15-8. PubMed ID: 18335856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use and significance of anti-CCP autoantibodies in rheumatoid arthritis.
    Zendman AJ; van Venrooij WJ; Pruijn GJ
    Rheumatology (Oxford); 2006 Jan; 45(1):20-5. PubMed ID: 16188946
    [No Abstract]   [Full Text] [Related]  

  • 5. [Usefulness of anti-cyclic citrullinated peptide antibodies (anti-CCP) for the diagnosis of rheumatoid arthritis].
    Araki C; Hayashi N; Moriyama M; Morinobu S; Mukai M; Koshiba M; Kawano S; Kumagai S
    Rinsho Byori; 2004 Dec; 52(12):966-72. PubMed ID: 15675342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of etanercept on anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis.
    Chen HA; Lin KC; Chen CH; Liao HT; Wang HP; Chang HN; Tsai CY; Chou CT
    Ann Rheum Dis; 2006 Jan; 65(1):35-9. PubMed ID: 15975966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of anti cyclic citrullinated peptide antibodies in Malaysian rheumatoid arthritis patients and its correlation with disease activity.
    Sockalingam S; Khuan CS; Sthaneshwar P
    Int J Rheum Dis; 2009 Sep; 12(3):211-5. PubMed ID: 20374348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-CCP antibodies, rheumatoid factors and anti-keratin antibodies: clinical value in established rheumatoid arthritis.
    Amri M; Sfar I; Ounallah HS; Dhaouadi T; Bel Hadj N; Abdelmoula L; Zouari R; Ayed K; Gorgi Y
    Tunis Med; 2011 Mar; 89(3):231-5. PubMed ID: 21387224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis treated with anti-tumour necrosis factor agents.
    Russell AS; Maksymowych WP; de Silva M
    Ann Rheum Dis; 2005 Dec; 64(12):1807. PubMed ID: 16284357
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anti-cyclic citrullinated peptide (CCP) antibodies].
    Mimori T
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():491-4. PubMed ID: 20942111
    [No Abstract]   [Full Text] [Related]  

  • 12. Women with rheumatoid arthritis negative for anti-cyclic citrullinated peptide and rheumatoid factor are more likely to improve during pregnancy, whereas in autoantibody-positive women autoantibody levels are not influenced by pregnancy.
    de Man YA; Bakker-Jonges LE; Goorbergh CM; Tillemans SP; Hooijkaas H; Hazes JM; Dolhain RJ
    Ann Rheum Dis; 2010 Feb; 69(2):420-3. PubMed ID: 19282308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-cyclic citrullinated peptide antibody and rheumatoid factor isotypes in Iranian patients with rheumatoid arthritis: evaluation of clinical value and association with disease activity.
    Shakiba Y; Koopah S; Jamshidi AR; Amirzargar AA; Massoud A; Kiani A; Nicknam MH; Nazari B; Nikbin B
    Iran J Allergy Asthma Immunol; 2014 Jun; 13(3):147-56. PubMed ID: 24659118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles.
    Irigoyen P; Lee AT; Wener MH; Li W; Kern M; Batliwalla F; Lum RF; Massarotti E; Weisman M; Bombardier C; Remmers EF; Kastner DL; Seldin MF; Criswell LA; Gregersen PK
    Arthritis Rheum; 2005 Dec; 52(12):3813-8. PubMed ID: 16320316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of rheumatoid factor isotypes and anti-cyclic citrullinated peptides in Malaysian rheumatoid arthritis patients.
    Gomez EL; Gun SC; Somnath SD; D'Souza B; Lim AL; Chinna K; Radhakrishnan AK
    Int J Rheum Dis; 2011 Feb; 14(1):12-7. PubMed ID: 21303477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated anticitrullinated protein antibody and rheumatoid factor assessment is not necessary in early arthritis: results from the ESPOIR cohort.
    Gossec L; Paternotte S; Combe B; Meyer O; Dougados M
    J Rheumatol; 2014 Jan; 41(1):41-6. PubMed ID: 24241481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles.
    Linn-Rasker SP; van der Helm-van Mil AH; van Gaalen FA; Kloppenburg M; de Vries RR; le Cessie S; Breedveld FC; Toes RE; Huizinga TW
    Ann Rheum Dis; 2006 Mar; 65(3):366-71. PubMed ID: 16014670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative clinical rheumatology: why is a test for anti-CCP antibodies included in most routine care for rheumatoid arthritis while a HAQ/MDHAQ remains largely a research tool?
    Pincus T; Yazici Y; Bergman MJ
    J Rheumatol; 2009 Aug; 36(8):1563-4. PubMed ID: 19671805
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparison and relevance of rheumatoid factors, antikeratin antibodies and anti-cyclic citrullinated peptides antibodies in rheumatoid arthritis].
    Galati S; Beauvillain C; Renier G; Jeannin P; Masson C; Chevailler A
    Ann Biol Clin (Paris); 2008; 66(2):157-64. PubMed ID: 18390426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is Anti Cyclic citrullinated peptide a useful laboratory test for the diagnosis of rheumatoid arthritis?
    Girelli F; Foschi FG; Bedeschi E; Calderoni V; Stefanini GF; Martinelli MG
    Eur Ann Allergy Clin Immunol; 2004 Apr; 36(4):127-30. PubMed ID: 15180353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.